Anesthesiology Doctors in Burlington, VT Accepting Medicare

85 Anesthesiology doctors found. Showing 81 - 85

Dr. Lyle P. Gerety, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, 111 Colchester Ave., Burlington, VT 05401 Phone: 802-847-2415    Fax: 802-847-5324

Eva A Kristensen, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Fahc-wp2, Burlington, VT 05401 Phone: 802-847-2415    Fax: 802-847-5324

Melissa Rafferty, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0231

Mark P Hamlin, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Fahc-wp2, Burlington, VT 05401 Phone: 802-847-2415    Fax: 802-847-5324

Guy Tousignant, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Fahc - Wp 2, Burlington, VT 05401 Phone: 802-847-2415    Fax: 802-847-5324

News Archive

Childhood psychological trauma can increase likelihood of drug misuse in adolescence

Latest research from a national sample of almost 10,000 U.S. adolescents found psychological trauma, especially abuse and domestic violence before age 11, can increase the likelihood of experimentation with drugs in adolescence, independent of a history of mental illness.

Atrial fibrillation more common among competition skiers

Next month, in the Norwegian town of Rena, 12,000 elite cross-country skiers will line up for this year's Birkebeiner ski marathon, an annual endurance race which will take them through 54 kilometres of snow-covered countryside to the winter sports resort of Lillehammer.

SOX2 directly regulated by tumor suppressor CDKN1B(p27) gene

A team of researchers from the Spanish National Cancer Research Centre (CNIO), led by Manuel Serrano, from the Tumour Suppression Group, together with scientists from London and Santiago de Compostela, has discovered that the cellular reprogramming gene SOX2, which is involved in several types of cancers, such as lung cancer and pituitary cancer, is directly regulated by the tumor suppressor CDKN1B(p27) gene, which is also associated with these types of cancer.

Amgen and Roche end EPO patent infringement dispute

Amgen announced today that the United States (U.S.) District Court in Boston has entered final judgment and a permanent injunction against Roche prohibiting Roche from infringing Amgen's patents on recombinant erythropoietin (EPO), thus bringing the five-year patent infringement dispute to an end.

Read more Medical News

› Verified 8 days ago

• 1
• 2
• 3
• 4
• 5(current)